Cargando…

Targeting Chemoprevention of Colorectal Cancer to Those Who Are Likely to Respond

In the past four decades, chemoprevention of colorectal cancer (CRC) has been the subject of many epidemiologic and intervention trials of naturally occurring or pharmacologic agents. Recently, the positioning of cyclooxygenase 2 inhibitors as a viable option in this context was a major breakthrough...

Descripción completa

Detalles Bibliográficos
Autor principal: Stockbrugger, Reinhold W.
Formato: Texto
Lenguaje:English
Publicado: Current Science Inc. 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2817803/
https://www.ncbi.nlm.nih.gov/pubmed/20157367
http://dx.doi.org/10.1007/s11888-009-0041-6